Delivery Order SPE2DR25D9113-SPE2DR26FCHR8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The award, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $26,113.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation, indicating the award was made through competitive procurement. The delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $2,436.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and was awarded on October 17, 2025. This award carries no set-aside designation, demonstrating the vendor's competitive capability in...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $9,044.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. This delivery order, awarded on October 20, 2025, represents one of numerous pharmaceutical procurement actions issued to the vendor during October 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a $5,021.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for EXPAREL 266 mg/20 ml vials. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the vendor competed in an unrestricted federal procurement environment. This award falls under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $25,106.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The order, valued at $1,218.44 with an ultimate completion date of September 24, 2025, was issued on September 3, 2025, under firm fixed-price terms with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, for EXPAREL 133 mg/10 ml vials valued at $15,072.20. This firm fixed-price delivery order, which is not associated with a set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 25, 2025. The award leverages DMS Pharmaceutical Group's position as a...
- The U.S. Defense Logistics Agency, under its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 1.3% 20ML in a quantity of 10 units. This firm fixed-price delivery order, valued at $7,531.89, was awarded on June 27, 2025, with an ultimate completion date of the same day. The award carries no set-aside designation, allowing DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on September 24, 2025, carries a ceiling value of $15,063.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025. This award utilizes no set-aside designation, demonstrating the vendor's competitive...
- SPE2DR25D9113Indefinite Delivery Contract
- SPE2DR25D9113-SPE2DR26FCHR8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,691.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL (133 mg/10 mL vial). This firm fixed-price delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025. DMS Pharmaceutical Group serves as a critical pharmaceutical supplier supporting Department of Defense healthcare operations globally under the broader $30.3 billion PPV-G GEN V acquisition strategy. The company's indefinite delivery contract, valued at $499,999,999 with a completion date of December 31, 2036, encompasses a 30-month base period with three 30-month option periods and authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The current delivery order for EXPAREL, a specialty surgical product used in local anesthesia applications, reflects the company's established performance in fulfilling diverse pharmaceutical requirements for military healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 10/28/25 |